Form 8-K - Current report:
SEC Accession No. 0001437749-20-021997
Filing Date
2020-10-29
Accepted
2020-10-29 16:24:02
Documents
14
Period of Report
2020-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lmat20201029_8k.htm   iXBRL 8-K 30524
2 EXHIBIT 99.1 ex_210016.htm EX-99.1 252318
  Complete submission text file 0001437749-20-021997.txt   432080

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lmat-20201029.xsd EX-101.SCH 3701
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lmat-20201029_def.xml EX-101.DEF 11587
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lmat-20201029_lab.xml EX-101.LAB 15467
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lmat-20201029_pre.xml EX-101.PRE 11741
7 EXTRACTED XBRL INSTANCE DOCUMENT lmat20201029_8k_htm.xml XML 2555
Mailing Address 63 SECOND AVENUE BURLINGTON MA 01803
Business Address 63 SECOND AVENUE BURLINGTON MA 01803 781-221-2266
LEMAITRE VASCULAR INC (Filer) CIK: 0001158895 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33092 | Film No.: 201272972
SIC: 3841 Surgical & Medical Instruments & Apparatus